These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 219009)

  • 1. The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Horner JM; Hintz RL; Luetscher JA
    J Clin Endocrinol Metab; 1979 May; 48(5):776-83. PubMed ID: 219009
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma aldosterone, renin activity, and 17alpha-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effect of 9alpha-fluorocortisol.
    Limal JM; Rappaport R; Bayard F
    J Clin Endocrinol Metab; 1977 Sep; 45(3):551-9. PubMed ID: 198427
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
    Loras B; Roux H; Audi-Parera L; David M; Bertrand J
    Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
    [No Abstract]   [Full Text] [Related]  

  • 4. Congenital adrenal hyperplasia: simultaneous determination of plasma aldosterone and 17-hydroxyprogesterone.
    Parth K; Zimprich H; Swoboda W; Brunel R; Bohrn E
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):148-57. PubMed ID: 202131
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of ACTH administration on aldosterone production in non salt-losing congenital adrenal hyperplasia.
    Beitins IZ; Bayard F; Kowarski A; Migeon CJ
    J Clin Endocrinol Metab; 1972 Oct; 35(4):595-603. PubMed ID: 4340790
    [No Abstract]   [Full Text] [Related]  

  • 6. The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia.
    Rösler A; Levine LS; Schneider B; Novogroder M; New MI
    J Clin Endocrinol Metab; 1977 Sep; 45(3):500-12. PubMed ID: 198425
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renin-angiotensin and hypophyseo-adrenal systems in children suffering from congenital adrenocortical hyperplasia resulting from 21-hydroxylase deficiency].
    Kasatkina EP; Tiul'pakov AN; Ibragimova GV; Litvinova NN
    Probl Endokrinol (Mosk); 1991; 37(6):p66. PubMed ID: 1664952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia.
    Godard C; Riondel AM; Veyrat R; Mégevand A; Muller AF
    Pediatrics; 1968 May; 41(5):883-904. PubMed ID: 5654836
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of angiotensin II to stimulate increases in concentrations of adrenal androgens, 17-hydroxyprogesterone, or adrenocorticotropin in congenital 21-hydroxylase deficiency.
    Wisgerhof M; Mellinger RC; Zafar MS
    J Clin Endocrinol Metab; 1983 Mar; 56(3):627-31. PubMed ID: 6296191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma renin activity and aldosterone concentration in normal subjects and patients with salt-losing type of congenital adrenal hyperplasia during infancy.
    Koshimizu T
    Clin Endocrinol (Oxf); 1979 May; 10(5):515-22. PubMed ID: 225066
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma renin activity in congenital virilizing adrenal hyperplasia.
    Imai M; Igarashi Y; Sokabe H
    Pediatrics; 1968 May; 41(5):897-904. PubMed ID: 5654837
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma 17-hydroxyprogesterone, 21-deoxycortisol and cortisol in congenital adrenal hyperplasia.
    Franks RC
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1099-102. PubMed ID: 4372245
    [No Abstract]   [Full Text] [Related]  

  • 13. Adult height and fertility in men with congenital virilizing adrenal hyperplasia.
    Urban MD; Lee PA; Migeon CJ
    N Engl J Med; 1978 Dec; 299(25):1392-6. PubMed ID: 152409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma 17-OH progesterone. Determination in normal children and in congenital adrenal hyperplasia due to the 21-hydroxylation deficiency].
    Chaussain JL; Estrada Y; Roger M; Tea NT; Scholler R; Canlorbe P; Job JC
    Nouv Presse Med; 1974 Dec; 3(44):2621-4. PubMed ID: 4376596
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of cortisol treatment on hormonal relationships in congenital adrenal hyperplasia.
    Bacon GE; Spencer ML; Kelch RP
    Obstet Gynecol Surv; 1977 Sep; 32(7):608-10. PubMed ID: 904792
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma aldosterone concentrations related to 17alpha-hydroxyprogesterone in congenital adrenal hyperplasia.
    Pham-Huu-Trung MT; Raux MC; Gourmelen M; Baron MC; Girard F
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):572-86. PubMed ID: 180741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Schaison G; Couzinet B; Gourmelen M; Elkik F; Bougneres P
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1390-4. PubMed ID: 7002950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cortisol treatment on hormonal relationships in congenital adrenal hyperplasia.
    Bacon GE; Spencer ML; Kelch RP
    Clin Endocrinol (Oxf); 1977 Feb; 6(2):113-26. PubMed ID: 844219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia.
    Hughes IA; Wilton A; Lole CA; Gray OP
    Arch Dis Child; 1979 May; 54(5):350-5. PubMed ID: 475410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin output in congenital adrenal hyperplasia before and after adrenal suppression.
    Klingensmith GJ; Wentz AC; Meyer WJ; Migeon CJ
    J Clin Endocrinol Metab; 1976 Oct; 43(4):933-6. PubMed ID: 185235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.